Vemlidy

Vemlidy Dosage/Direction for Use

tenofovir alafenamide

Manufacturer:

Gilead

Distributor:

DCH Auriga
Full Prescribing Info
Dosage/Direction for Use
Always take this medicine exactly as the doctor has told. Check with the doctor or pharmacist if unsure.
The recommended dose is one tablet once a day. Treatment should continue for as long as the doctor advises. Usually this is for at least 6 to 12 months and may be for many years.
Do not stop taking Vemlidy without the doctor's advice. Stopping treatment with Vemlidy may cause hepatitis B to get worse. In some patients with advanced liver disease or cirrhosis, this could be life threatening. If the patient stops taking Vemlidy, they will need regular health checks and blood tests for several months to check hepatitis B infection.
Talk to the doctor before stopping Vemlidy for any reason, particularly if the patient is experiencing any side effects or they have another illness.
Tell the doctor immediately about new or unusual symptoms after stopping treatment, particularly symptoms associated with hepatitis B infection.
Talk to the doctor before restarting taking Vemlidy tablets.
If there are any further questions on the use of this medicine, ask a doctor or pharmacist.
It is important not to miss a dose of Vemlidy. If a dose is missed, work out how long since they should have taken it.
If it is less than 18 hours after the patient usually take Vemlidy, take it as soon as they can, and then take the next dose at its regular time.
If it is more than 18 hours after the patient usually take Vemlidy, then do not take the missed dose. Wait and take the next dose at the regular time. Do not take a double dose to make up for a forgotten tablet.
If the patient becomes sick (vomit) less than 1 hour after taking Vemlidy, take another tablet. The patient do not need to take another tablet if the patient is sick (vomit) more than 1 hour after taking Vemlidy.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in